# A Clinical Study of B007 in the Treatment of Pemphigus.

> **NCT06454357** · PHASE2,PHASE3 · RECRUITING · sponsor: **Shanghai Jiaolian Drug Research and Development Co., Ltd** · enrollment: 132 (estimated)

## Conditions studied

- Pemphigus

## Interventions

- **DRUG:** B007

## Key facts

- **NCT ID:** NCT06454357
- **Lead sponsor:** Shanghai Jiaolian Drug Research and Development Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454357, "A Clinical Study of B007 in the Treatment of Pemphigus.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06454357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*